Physician profile
Rona L Stein
NPI 1477657997
$970.49
in general payments reported to CMS, 2019-2025
14 companies · $225 in 2025
The $225 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $182 · 2020: $45.09 · 2021: $26.49 · 2022: $37.20 · 2023: $200 · 2024: $255 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $161.58 | 2019-2023 | Vaxelis, Gardasil 9, Vaxneuvance |
| Sanofi Pasteur INC. | $158.87 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $125.27 | 2024 | Qelbree |
| Pfizer INC. | $121.74 | 2019-2025 | |
| Corium, LLC | $113.95 | 2023 | Azstarys |
| Glaxosmithkline, LLC. | $76.79 | 2019-2023 | Bexsero |
| Cranial Technologies, INC | $41.74 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $37.61 | 2024-2025 | Flumist Quadrivalent |
| Cumberland Pharmaceuticals, INC. | $31.49 | 2025 | Kristalose |
| Alk-Abello, INC | $23.78 | 2025 | Ragwitek, Odactra, Grastek |
| Phadia US INC. | $22.99 | 2020 | |
| Genzyme Corporation | $22.85 | 2024 | |
| Seqirus USA INC | $20.34 | 2025 | Flucelvax |
| Amneal Pharmaceuticals LLC | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rona Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.